{"product_id":"harvard-diabetes-comorbidities-and","title":"Harvard Diabetes Comorbidities And Complications 2024 (Videos With Captions + Slides)","description":"Harvard Diabetes Comorbidities And Complications 2024 (Videos With Captions + Slides)\u003cbr\u003e\u003cbr\u003eComprehensive Updates for State-of-the-Art Diagnosis, Management, and Prevention\u003cbr\u003eDiabetes Comorbidities and Complications will be held online, using live streaming, electronic Q\u0026amp;A, and other remote learning technologies.\u003cbr\u003eThis comprehensive course provides education and updates to optimize your care of patients with diabetes and these conditions:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eObesity\u003c\/li\u003e\n\u003cli\u003eCardiovascular Disease\u003c\/li\u003e\n\u003cli\u003eHeart Failure\u003c\/li\u003e\n\u003cli\u003eCoronary Artery Disease\u003c\/li\u003e\n\u003cli\u003eCerebrovascular Disease\u003c\/li\u003e\n\u003cli\u003eHypertension\u003c\/li\u003e\n\u003cli\u003eHyperglycemia\u003c\/li\u003e\n\u003cli\u003eHypoglycemia\u003c\/li\u003e\n\u003cli\u003eDyslipidemia\u003c\/li\u003e\n\u003cli\u003eMetabolic-Associated Fatty Liver Disease\u003c\/li\u003e\n\u003cli\u003eChronic Kidney Disease\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eSessions are led by experts in these conditions and their impact on the patient with diabetes. Faculty deliver practical education that is focused on:\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eAdvancing your knowledge of diabetes comorbidities and complications\u003c\/li\u003e\n\u003cli\u003eDelivering state-of-the-art approaches to evaluation and management of the patient with diabetes and these conditions\u003c\/li\u003e\n\u003cli\u003eIdentifying practical strategies to reduce the risk of diabetes comorbidities and complications\u003c\/li\u003e\n\u003cli\u003eOptimizing clinical decision-making\u003c\/li\u003e\n\u003cli\u003eImproving patient outcomes\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eIn addition to their clinical expertise, faculty have been chosen for their inspirational teaching skills and their ability to provide specific recommendations to incorporate the vast number of recent updates covered in this program into day-to-day clinical practice.\u003cbr\u003e\u003ch3\u003eEDUCATIONAL HIGHLIGHTS\u003c\/h3\u003e\u003cbr\u003eThis program provides strategies, updates, and new practice recommendations to improve your care of patients with (and at risk for) diabetes complications and comorbidities. Participants can rely on this program for updates that ensure state-of-the-art:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003ePREVENTION and RISK REDUCTION\u003c\/li\u003e\n\u003cli\u003eDIAGNOSIS\u003c\/li\u003e\n\u003cli\u003eMANAGEMENT\u003c\/li\u003e\n\u003cli\u003eUSE of the NEWEST DIABETES DRUGS, TECHNOLOGIES, and DEVICES\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch5\u003ePREVENTION and RISK REDUCTION\u003c\/h5\u003e\u003cbr\u003eNew algorithms for evaluating cardiovascular and renal risk in patients with diabetes\u003cbr\u003eMedical treatment and lifestyle interventions to prevent:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eCardiovascular disease\u003c\/li\u003e\n\u003cli\u003eKidney disease\u003c\/li\u003e\n\u003cli\u003eCerebrovascular disease\u003c\/li\u003e\n\u003cli\u003eHyper- and hypoglycemia\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eMedication interactions: avoiding adverse outcomes\u003cbr\u003eImpact of the newest pharmacological tools to reduce CV and renal disease development and progression\u003cbr\u003e\u003ch3\u003eDIAGNOSIS\u003c\/h3\u003e\n\u003ch4\u003eExpanded options for diagnosis of:\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eCoronary artery disease\u003c\/li\u003e\n\u003cli\u003eHeart failure\u003c\/li\u003e\n\u003cli\u003eCerebrovascular disease\u003c\/li\u003e\n\u003cli\u003eChronic kidney disease\u003c\/li\u003e\n\u003cli\u003eMetabolic-associated fatty liver disease\u003c\/li\u003e\n\u003cli\u003eHypoglycemia\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eMANAGEMENT\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eAdjusting pharmacological therapies in the patient with diabetes complications\u003c\/li\u003e\n\u003cli\u003eEvaluating, managing, and monitoring diabetic CKD\u003c\/li\u003e\n\u003cli\u003eObesity management: when to consider new therapeutic and surgical options\u003c\/li\u003e\n\u003cli\u003eDiagnosis and management of coronary artery disease in the patient with diabetes\u003c\/li\u003e\n\u003cli\u003eManagement of kidney disease in the patient with diabetes\u003c\/li\u003e\n\u003cli\u003eHypertension and cholesterol management: customizing targets and treatment strategies for each patient\u003c\/li\u003e\n\u003cli\u003eHeart failure: improving patient functional capacity with combined therapies\u003c\/li\u003e\n\u003cli\u003eManagement of cerebrovascular disease\u003c\/li\u003e\n\u003cli\u003eUpdates in the management of hyper- and hypoglycemia\u003c\/li\u003e\n\u003cli\u003eCurrent guidelines for treating metabolic-associated fatty liver disease\u003c\/li\u003e\n\u003cli\u003eCombining innovative therapeutic combinations with traditional approaches\u003c\/li\u003e\n\u003cli\u003eStrategies to assess and manage interacting comorbidities\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eINCORPORATING NEW DRUGS, TECHNOLOGIES, and DEVICES INTO PRACTICE\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eThe expanded roles of SGLT-2 inhibitors, MRA, and GLP-1 RA in treating CV and renal disease\u003c\/li\u003e\n\u003cli\u003ePractical recommendations for the use of GLP-1 RA, SGLT-2 inhibitors, and MRA\u003c\/li\u003e\n\u003cli\u003eAdvances in glucose monitors, insulin pumps, and diabetes apps\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSOCIAL, RACIAL, SEXUAL, and CULTURAL DIFFERENCES IN DIABETES CARE NEEDS\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eWe are committed to offering the best practices for health care equity and the needs of diverse patient populations. Highlights include:\u003c\/li\u003e\n\u003cli\u003eManagement of diabetes and related disorders in diverse racial\/ethnic populations\u003c\/li\u003e\n\u003cli\u003eRecognizing biases: strategies for achieving equity and addressing disparities\u003c\/li\u003e\n\u003cli\u003eEstablishing and maintaining connections with patients\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954417209442,"sku":"MED-AMB03133","price":90.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Harvard-Diabetes-Comorbidities-And-Complications-2024-Videos-With-Captions-Slides.jpg?v=1779375998","url":"https:\/\/meducourse.com\/products\/harvard-diabetes-comorbidities-and","provider":"Meducourse","version":"1.0","type":"link"}